Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 137K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Algeciras, A. Articles by Paya, C. V. Search for Related Content PubMed PubMed Citation Articles by Algeciras, A. Articles by Paya, C. V. Social Bookmarking                            What's this?

Articles

Alicia Algeciras^*, David H. Dockrell, David H. Lynch, and Carlos V. Paya^*,

From the ^* Department of Immunology and the Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota 55905; and the Department of Immunobiology, Immunex Corporation, Seattle, Washington 98101

The current knowledge of CD4 function is limited to its role as a necessary coreceptor in TCR-initiated signaling. We have investigated whether CD4 regulates additional T cell functions. Using human primary resting CD4⁺ T cells, we demonstrate that CD4 activation is sufficient to induce lymphocyte death. Immediately after CD4 cross-linking, CD4⁺ T cells are rendered susceptible to apoptosis mediated by TNF or FasL. This, together with the concomitant induction of FasL within the same population, results in significant CD4⁺ T cell death in vitro. The CD4-dependent induction of susceptibility to apoptosis that is mediated by TNF or FasL is protein synthesis independent but phosphorylation dependent. After CD4 activation, PKC regulates susceptibility to apoptosis mediated by FasL but not the induction of susceptibility to TNF-dependent apoptosis. Moreover, significant differences between CD3 and CD4 activation were observed with regards to the kinetics of induction of CD4⁺ T cell susceptibility to FasL- and TNF-mediated apoptosis. Altogether, these results provide a model with which to study the molecular mechanisms regulating lymphocyte survival after CD4 activation, and highlight the potential role of CD4 in controlling lymphocyte apoptosis under physiological conditions or in disease states such as HIV infection.

Address correspondence to Carlos V. Paya, Mayo Clinic, 200 First St. SW, Guggenheim 501, Rochester, MN 55905. Phone: 507-284-3747; Fax: 507-284-3757; E-mail: paya{at}mayo.edu

¹ Abbreviations used in this paper: FasL, Fas ligand; GF, PKC inhibitor GF109203X; gp, glycoprotein; PKC, protein kinase C; XL, cross-linking.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS